ARCHIVES

Local Labs Not As Accurate As Central Testing For HER2

This article is from The Cancer Letter archive.

Vol. 25 No. 8 | August 30, 2002

Download PDF Visit The Full Archive

Related Articles

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

Mammography Panel Reaches Consensus On Most Issues

September 23, 1977

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

March 2, 2001

NCI T Use Ames Test In Carcinogenesis Testing Program

December 3, 1976

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997

In Brief: Little Doubt That DeVita, Frederickson Will Keep Their Jobs; New DCT Projects May Not Be Funded

March 6, 1981